Professor Gabriele Lignani on developing new gene therapies for neuropsychiatric disorders

During Brain Awareness Week, we highlighted how research at UCL is transforming our understanding of the brain. 

In the video below , Professor Gabriele Lignani discusses how their international team of researchers develop a new generation of cell-state gene therapies for neuropsychiatric disorders.

The project seeks to address challenges of existing drug therapies for neuropsychiatric disorders such as epilepsy, schizophrenia and dementia, which affect the entire brain and often affect other organs as well.

The UCL Translational Research Office (TRO) is pleased to have supported Prof. Lignani in advancing novel therapies and remains committed to supporting UCL researchers in translating discoveries into impact.

Find out more about the new gene therapy here.

Discover how UCL academics are driving groundbreaking discoveries and innovations.

YouTube Widget Placeholderhttps://youtu.be/ZA8B9oTCt5s?si=1Bx-_nYz443AAy9v

Credit: UCL Faculty of Brain Sciences

Interested to stay informed of upcoming news, events and funding calls?

• Subscribe to our newsletter and you would automatically become a member of UCL TINs (Therapeutic Innovation Networks) and be the first to receive our event invitations

• Follow us on social media (LinkedIn, Bluesky, X) and stay tuned to our news and updates.